Search results for "Rheumatoid arthritis"


 
Results 21 - 30 of about 135 for "Rheumatoid arthritis".
Sort by: Relevance | Newest | Oldest

Changes to contraindication for statins in pregnancy

This column reviews details on recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2021/09/changes-to-contraindication-for-statins-in-pregnancy.htm
1 Sep 2021

NIH adds another antibody to recommended treatments, studies look at early cases, racial disparities

Recent COVID-19 news includes a new NIH recommendation and studies of the earliest U.S. cases, an experimental inpatient drug, and potential causes of racial disparities in outcomes.
https://immattersacp.org/weekly/archives/2021/06/22/1.htm
22 Jun 2021

Handling hoarseness, hearing problems in primary care

Internists can help patients cope with common ENT conditions like hoarseness, tinnitus, and hearing loss.
https://immattersacp.org/archives/2021/06/handling-hoarseness-hearing-problems-in-primary-care.htm
1 Jun 2021

MKSAP Quiz: 3-day history of left knee pain, swelling

A 43-year-old woman is evaluated for a 3-day history of left knee pain and swelling. Similar episodes have occurred in either knee as well as the left wrist during the past 2 years. Following a physical exam, radiographs, and joint aspiration of the left knee, what laboratory study will most likely identify the cause of this patient's symptoms?
https://immattersacp.org/weekly/archives/2021/03/16/3.htm
16 Mar 2021

Inappropriate medications prescribed in some Medicare patients with CKD, study finds

Over a third of patients with chronic kidney disease (CKD) enrolled in a Medicare plan's Medication Therapy Management program in 2018 received a prescription for at least one potentially inappropriate medication.
https://immattersacp.org/weekly/archives/2021/02/02/5.htm
2 Feb 2021

Latest COVID-19 guidelines come out against bamlanivimab, remdesivir

The NIH and the Infectious Diseases Society of America found insufficient data to support bamlanivimab, while the World Health Organization said the same about remdesivir. The FDA issued more emergency use authorizations, and research looked at racial and other disparities in COVID-19 outcomes.
https://immattersacp.org/weekly/archives/2020/11/24/1.htm
24 Nov 2020

Latest updates on ACP's priorities, initiatives

ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, ACP Internist Weekly.
https://immattersacp.org/archives/2020/11/latest-updates-on-acps-priorities-initiatives.htm
1 Nov 2020

Glucocorticoids associated with increased infection risk even at low doses

Patients taking glucocorticoids for rheumatoid arthritis had a significant, dose-dependent increased risk for infections requiring hospitalization, and the results should be considered in prescribing for these patients, according to an accompanying editorial.
https://immattersacp.org/weekly/archives/2020/09/22/2.htm
22 Sep 2020

MKSAP Quiz: 3-year history of severe rheumatoid arthritis

A 67-year-old woman is evaluated for a 3-year history of severe rheumatoid arthritis. After some changes in therapy, she has done well with tocilizumab and methotrexate over the past year. She notes several months of prominent fatigue. Lab studies demonstrate anemia. What is its most likely cause?
https://immattersacp.org/weekly/archives/2020/09/01/5.htm
1 Sep 2020

Need for hip, knee replacement appears reduced with canakinumab, industry-funded study finds

An editorial noted that a novel entry criterion may have identified a subgroup of patients with accelerated joint degeneration.
https://immattersacp.org/weekly/archives/2020/08/04/4.htm
4 Aug 2020

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next